Proteus Digital Health
Proteus Digital Health published a paper on its ingestible sensor that explains the design of the sensor, the safety tests Proteus completed, and the clinical trials Proteus conducted with 412 patients who used the system over 5,656 days.
The Proteus digital medicine platform is a medication management and adherence system that includes unique measurement tools, like...
Digital medicine company Proteus Digital Health has raised an additional $52 million from undisclosed investors following a whopping $120 million raise the company announced just last month. That brings Proteus' latest round of funding -- its seventh -- to $172 million. By our count the company's total known funding is now close to $400 million, which makes it one of the most-funded, private...
Proteus Digital Health has raised $120 million from new, undisclosed investors described as "major new institutional investors based in the United States, Europe and Asia." The company will use the funding to continue its plans to commercialize its ingestible sensor system at scale, as well as to continue demonstrating the value of the technology on health outcomes and costs.
The Proteus digital...
Proteus Biomedical's Raisin system
Redwood City, California-based Proteus Digital Health announced that it had raised $62.5 million in its latest round of funding led by Oracle with participation from existing investors Otsuka, Novartis, Sino Portfolio and others. MobiHealthNews reported on the first $17.5 million that Proteus raised for this round a year ago, so the $62.5 million includes an...
Proteus Biomedical's Raisin system
Proteus Digital Health, formerly known as Proteus Biomedical, has become the first company to receive Food and Drug Administration clearance for an ingestible biomedical sensor that monitors medication adherence.
The FDA granted 510(k) premarket approval to the Proteus Ingestible Event Marker (IEM) as a de novo medical device, meaning that there was no similar...
Proteus Biomedical's Raisin system
Intelligent medicine platform developer Proteus Biomedical has changed its name to Proteus Digital Health, to "better reflect" what the company does, Chief Product Officer David O'Reilly told MobiHealthNews in an email this week. Proteus also inked a deal with Japan-based Otsuka Pharmaceutical, which is known for its Abilify drug for schizophrenia and bipolar...
Photo Credit: Paul Savage Photography
By Padma Nagappan
Misfit Wearables, the wearable computing start-up with $7.6 million in funding, founded by Sonny Vu and Sridhar Iyengar, co-founders of AgaMatrix, and former Apple CEO John Sculley, has kept mum on what it's developing. During his presentation at the WLSA Convergence Summit in San Diego this week, Vu didn't reveal any secrets, but rather...
Wearable body monitor company BodyMedia has raised another $9.3 million in its most recent round of funding, which we reported on in late March, to make for a $12 million funding round. Newcomer Comcast Ventures led the round, which also included previous investors Draper Fisher Jurvetson ePlanet, Draper Triangle Ventures, Ascension Health Ventures and InCube Ventures. The company plans to use...
Proteus Biomedical's Raisin system
Proteus Biomedical raised about $17.5 million in a round of funding it hopes will eventually top $50 million, according to a regulatory filing. The Redwood, California-based company developed an "intelligent medicine" suite of technology called Raisin, which includes, an ingestible biomedical sensor, a wearable, peel-and-stick patch, and a companion smartphone...
In recent months a number of deals, acquisitions, service and product launches have led to a growing discussion around the mobile health opportunities for pharma companies. There seem to be three big ones vying for the top.
Is it adding connectivity to clinical trials?
Earlier this month research analyst firm Cutting Edge Information (CEI) published a report that suggested pharma companies look...
